J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 803.9 INR -1.18% Market Closed
Market Cap: 282.5B INR

During the last 3 months J B Chemicals and Pharmaceuticals Ltd insiders bought 36.4m INR , and have not sold any shares. The stock price has increased by 5% over this period (open performance analysis).

The last transaction was made on Nov 23, 2025 by Dilip Singh Rathore , who bought 36.4m INR worth of JBCHEPHARM shares.

Last Transactions:
Dilip Singh Rathore
₹+36.4m
Pranav Shah
₹+8.3m
View All Transactions

During the last 3 months J B Chemicals and Pharmaceuticals Ltd insiders bought 36.4m INR , and have not sold any shares. The stock price has increased by 5% over this period (open performance analysis).

The last transaction was made on Nov 23, 2025 by Dilip Singh Rathore , who bought 36.4m INR worth of JBCHEPHARM shares.

Sold
0-3
months
0 INR
0
3-6
months
0 INR
0
6-9
months
0 INR
0
9-12
months
0 INR
0
Bought
0-3
months
1
36.4m INR
3-6
months
No Insider Transactions
0
0 INR
6-9
months
No Insider Transactions
0
0 INR
9-12
months
No Insider Transactions
0
0 INR

J B Chemicals and Pharmaceuticals Ltd
Insider Trading Chart

J B Chemicals and Pharmaceuticals Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

J B Chemicals and Pharmaceuticals Ltd
Last Insider Transactions

Global
Insiders Monitor

J B Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
280.8B INR
Industry
Pharmaceuticals

In the bustling marketplace of India's pharmaceutical industry, J B Chemicals and Pharmaceuticals Ltd. has carved its niche, a testament to its strategic vision and operational prowess. Founded in 1976 by Janak Mehta, the company has grown from its humble beginnings into a leading player in both the domestic and international arenas. Originally rooted in the ethos of quality and innovation, it established a firm foothold in the pharmaceutical sector through a diverse portfolio that includes formulations, active pharmaceutical ingredients (APIs), and contract manufacturing. As a vertically integrated company, J B Chemicals leverages its ability to control the manufacturing process from start to finish, ensuring strict quality measures and cost efficiencies, vital in tackling industry competition and regulatory challenges. The heart of J B Chemicals’ revenue model is its well-rounded product line that spans a range of therapeutic categories, including gastrointestinal, cardiovascular, and anticold segments. Blockbuster brands like Cilacar and Metrogyl have propelled the company to the top ranks within India, while its export division flourishes, contributing significantly to total earnings. With footprints in more than 30 countries, particularly in Russia and South Africa, the company taps into the growing demand for generic medicines worldwide. Moreover, by embracing innovation and investing in research and development, J B Chemicals continues to introduce new and improved medical solutions, positioning itself as a dynamic player in meeting global healthcare needs.

JBCHEPHARM Intrinsic Value
1 461.47 INR
Overvaluation 19%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top